Nasacort AQ Side Effects

Please note - some side effects for Nasacort AQ may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Nasacort AQ - for the Consumer

Nasacort AQ Spray

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Nasacort AQ Spray:

Cough; nosebleed; sore throat.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); muscle weakness; nasal discomfort; repeated nosebleeds; unusual or persistent stomach upset; unusual weight gain, especially in the face; white patches in the mouth.

Side Effects by Body System

General

Triamcinolone nasal has been generally well tolerated and, due to the nature of its administration, has not been inclined to produce the systemic adverse effects generally associated with the use of corticosteroids.

Nervous system

The central nervous system side effect of headache has been reported in 18% of patients.

Respiratory

Respiratory side effects have included nasal irritation, pharyngitis, dry mucous membranes, burning and stinging, congestion, epistaxis, sneezing, and rarely, nasal septal perforations.

Endocrine

Endocrine side effects have included rare reports of suppression of the hypothalamus-pituitary-adrenal axis. The risk of adrenal suppression is less than that associated with systemic corticosteroids and is generally only of concern when using higher than recommended doses or in patients who may be particularly sensitive.

Ocular

Ocular adverse effects are more commonly seen with systemic administration of corticosteroids. However, posterior capsular cataracts have been occasionally reported with triamcinolone, especially with long-term use. In addition, prolonged use of high-dose inhaled corticosteroids ( >= 440 mcg of triamcinolone nasal) may be associated with increased risk of ocular hypertension and open angle glaucoma.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.